Back to results
US 2003/0148460 A1Published application
Phosphodiester alpha-GlcNAcase of the lysosomal targeting pathway
AssigneeNovazyme Pharmaceuticals, Inc.
InventorWilliam M. Canfield
Life of this patent
Estimating the term…
Abstract
The present invention provides nucleotide and amino sequences of the lysosomal targeting pathway enzyme phosphodiester α-GlcNAcase, methods of producing and methods of purifying this enzyme.
Claims19
An isolated phosphodiester α-GlcNAcase.
A method of producing a phosphodiester α-GlcNAcase in a cell comprising
- transfecting into said cell a DNA construct comprising a targeting sequence homologous to a target site within or upstream of a endogenous phosphodiester α-GlcNAcase gene contained in the cell, wherein said endogenous gene comprises the sequence in SEQ ID NO:7, an exogenous regulatory sequence, an exon, and an unpaired splice-donor site at the 3′ end of the exon, wherein said transfecting generates a homologously recombinant cell in which the splice-donor site is operatively linked to the second exon of the endogenous gene, and the exogenous regulatory sequence controls transcription of the construct driven, the endogenous gene, and any sequence lying between the construct-driven exon and the endogenous gene, to produce a RNA transcript that encodes the phosphodiester α-GlcNAcase, so that the homologously recombinant cell produces the phosphodiester α-GlcNAcase.
Dependencies are inferred from the claim text.